Hospital General Universitario Gregorio Marañón at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Hospital General Universitario Gregorio Marañón takes part in 4 sessions at ESMO 2026 in Madrid, its home city. Its sessions focus on targeted treatment choices in hormone receptor-positive early breast cancer, EGFR-mutant non-small cell lung cancer and early-stage melanoma. Topics include oral selective estrogen receptor degraders as hormone therapy after surgery, and finding lung cancer patients with actionable genetic changes who may suit antibody-drug conjugates.
| Organization | ESMO 2026 Attendance |
|---|---|
HG Hospital General Universitario Gregorio Marañón Madrid, Spain | |
Public general university hospital in Madrid, Spain, affiliated with the Complutense University of Madrid. | Satellite Sun Oct 25 13:25–13:45 Satellite Sun Oct 25 13:27–13:52 Shaping long-term outcomes in first-line treatment for EGFR-mutant NSCLC Lung & thoracic cancers Satellite Sun Oct 25 18:30–20:00 Daiichi Sankyo - Patient Identification in NSCLC: 10 From Actionable Genomic Alterations to Emerging ADC Opportunities Lung & thoracic cancersBiomarkers & precision oncology Satellite Sun Oct 25 18:30–18:40 Welcome & Introduction Lung & thoracic cancersBiomarkers & precision oncology Satellite Sun Oct 25 18:55–19:20 Adjuvant Treatment Approaches for Early-stage Melanoma Melanoma & skin cancers Satellite Sun Oct 25 19:40–20:00 Audience Q&A and Panel Discussion Melanoma & skin cancers Satellite Sun Oct 25 19:40–20:00 Audience Q&A, Key Takeaways, and Close Lung & thoracic cancersBiomarkers & precision oncology |
Instantly find 20 buyers from Hospital General Universitario Gregorio Marañón
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction